26 August 2021 in International Journal of Dermatology
15 July 2021 in Dermatology Online Journal
To investigate the extent to which dermatology programs use social media to connect with applicants, we conducted a search of all 140 residency programs on Instagram, Facebook, Twitter, and YouTube. Our search revealed 74 (53%) Instagram, 21 (15%) Facebook, 20 (14%) Twitter, and four (3%) YouTube accounts for dermatology programs, with the number of Instagram accounts increasing five-fold from the end of 2019 to present. Our results demonstrate that conditions created during the coronavirus disease 2019 (COVID-19) pandemic accelerated dermatology residency programs' acceptance of social media, particularly Instagram, as a means to communicate and share information with applicants.
1 August 2022 in Journal of the American Academy of Dermatology
22 February 2023 in Mayo Clinic Proceedings: Digital Health
Artificial intelligence and clinical software solutions are augmenting patient care, optimizing clinical workflows, and altering health care organization operations. The regulation and oversight mechanisms under development for this wave of digital innovation will set the precedent for health care and play a key role in shaping the future of digital health. It is critical for the physician voice to be active in both policy making and product development to ensure that clinical outcomes and the needs of patients are prominently represented. With digital technology rapidly changing health care, it can be difficult for practicing physicians to participate in the future while simultaneously tending to their clinical duties. We aim to ease this cognitive burden by providing physicians a primer for current regulation of software and artificial intelligence by the Food and Drug Administration. Regulation and oversight will greatly benefit from physicians primed to add their knowledge and patient-first values to the future of digital technology.
15 June 2023 in Clinical and Experimental Dermatology
Evaluation of basal cell carcinoma (BCC) involves tangential biopsies of a suspicious lesion that is sent for frozen sections and evaluated by a Mohs micrographic surgeon. Advances in artificial intelligence (AI) have made possible the development of sophisticated clinical decision support systems to provide real-time feedback to clinicians that could have a role in optimizing the diagnostic workup of BCC. There were 287 annotated whole-slide images of frozen sections from tangential biopsies, of which 121 contained BCC, that were used to train and test an AI pipeline to recognize BCC. Regions of interest were annotated by a senior dermatology resident, an experienced dermatopathologist and an experienced Mohs surgeon, with concordance of annotations noted on final review. Final performance metrics included a sensitivity and specificity of 0.73 and 0.88, respectively. Our results on a relatively small dataset suggest the feasibility of developing an AI system to aid in the workup and management of BCC.
1 August 2020 in JAAD Case Reports